You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
密迪斯肌(08307.HK)2022年淨利390萬港元 同比增加311.5%
格隆匯 06-20 21:42

格隆匯6月20日丨密迪斯肌(08307.HK)公吿,截至2022年3月31日止年度全年業績,集團收益為4910萬港元,同比增加17.8%,此乃由於2021年本地消費者情緒有所改善及上一財政年度的比較基數偏低所致。集團錄得公司擁有人應占溢利390萬港元,同比增加311.5%。年內每股基本盈利為0.99港仙,較去年的0.23港仙增加330.4%。

公司擁有人應占年內溢利增加乃主要由於截至2022年3月31日止年度(與上一財政年度相比),集團的收益增加740萬港元或17.8%,部分被並無出售一間附屬公司的收益70萬港元,亦無收取政府補助金230萬港元所抵銷。

作為香港醫學皮膚護理行業的其中一名先鋒,公司將充分利用自身優勢,繼續尋求發展機遇。公司相信集團久負盛名,多年來被視作可信賴、可依靠及高品質的皮膚護理服務提供商,同時致力保持專業的服務水準,包括把客户的安全及福祉放在首位,因而令公司在同行中脱穎而出。為應對日後的挑戰,集團將繼續集中探索及推出各種新服務及產品,增加現有業務的市場份額以及物色新的業務機遇,務求為公司的客户及公司股東帶來價值。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account